Pre-clinical studies have shown that injection of allogeneic T cells primed against a single minor histocompatibility antigen (MiHA) could cure hematologic cancers (HC) without causing any ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback